Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-28

Clinical Trial Update: Ascorbic Acid and Thiamine Effect in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on the effect of ascorbic acid and thiamine in septic shock/sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ascorbic acid (Vitamin C)
  • Thiamine (thiamine)

Snippet

Sponsor: Tae Gun Shin | Conditions: Septic Shock, Sepsis | Phase 2 | Status: COMPLETED